INDIVIDUALIZATION OF PHENYTOIN DOSAGE REGIMENS

被引：0
|
作者：
LUDDEN, TM
ALLEN, JP
VALUTSKY, WA
VICUNA, AV
NAPPI, JM
HOFFMAN, SF
WALLACE, JE
LALKA, D
MCNAY, JL
机构：
[1] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,COLL PHARM,DEPT PHARM,ARLINGTON,TX 76010
[3] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284
[4] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284
[5] AUDIE MURPHY VET ADM HOSP,SAN ANTONIO,TX
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1977年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：287 / 293
页数：7
相关论文
共 50 条
  • [41] INDIVIDUALIZATION OF ORAL THEOPHYLLINE DOSAGE IN ELDERLY PATIENTS
    TALSETH, T
    KORNSTAD, S
    BOYE, NP
    BREDESEN, JE
    ACTA MEDICA SCANDINAVICA, 1981, 210 (06): : 489 - 492
  • [42] SERUM LEVEL APPROACH TO INDIVIDUALIZATION OF DRUG DOSAGE
    KOCHWESER, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (01) : 1 - 8
  • [43] Software for Dosage Individualization of Voriconazole for Immunocompromised Patients
    Hope, William W.
    VanGuilder, Michael
    Donnelly, J. Peter
    Blijlevens, Nicole M. A.
    Bruggemann, Roger J. M.
    Jelliffe, Roger W.
    Neely, Michael N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1888 - 1894
  • [44] Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
    N Bleyzac
    G Souillet
    P Magron
    A Janoly
    P Martin
    Y Bertrand
    C Galambrun
    Q Dai
    P Maire
    RW Jelliffe
    G Aulagner
    Bone Marrow Transplantation, 2001, 28 : 743 - 751
  • [45] Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
    Bleyzac, N
    Souillet, G
    Magron, P
    Janoly, A
    Martin, P
    Bertrand, Y
    Galambrun, C
    Dai, Q
    Maire, P
    Jelliffe, RW
    Aulagner, G
    BONE MARROW TRANSPLANTATION, 2001, 28 (08) : 743 - 751
  • [46] INDIVIDUAL VARIATION IN PHENYTOIN DOSAGE REQUIREMENTS
    MAHEENDRAN, KK
    BAROT, MH
    GRANT, RHE
    MAWER, GE
    WOODCOCK, BG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (05) : P952 - P953
  • [47] PHENYTOIN DOSAGE IN AMBULANT EPILEPTIC PATIENTS
    TERRENCE, C
    ALBERTS, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1978, 41 (05) : 463 - 465
  • [48] PHARMACOKINETIC INDEX FOR PHENYTOIN DOSAGE IN CHILDREN
    ALBANI, M
    KLINISCHE WOCHENSCHRIFT, 1978, 56 (09): : 476 - 476
  • [49] PHENYTOIN DOSAGE ADJUSTMENT IN AN OFFICE PRACTICE
    WELTY, TE
    ROBINSON, FC
    MAYER, PR
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 499 - 499
  • [50] PHENYTOIN DOSAGE REQUIREMENTS AND PHARMACOKINETIC VARIABLES
    TAYLOR, JW
    MURPHY, MJ
    BERG, MJ
    PERRY, PJ
    LYON, LW
    LUDDEN, TM
    CLINICAL PHARMACY, 1983, 2 (03): : 253 - 257
12345